However, before drawing conclusions on potential clinical implications of stromal PAR-1 in NSCLC, it is important to elucidate the functional consequence of PAR-1 activation on stromal cells with respect to lung cancer development. The gene discussed is F2R; the disease is non-small cell lung carcinoma.